Dana Huskens, PhD

PhD, Senior Research Project Leader
Synapse Research Institute
Maastricht, Limburg, Netherlands

Dana was born in Belgium and studied Biomedical Sciences at the KU Leuven. She obtained her PhD in 2010, with a research topic on HIV inhibitors targeting the early stages of infection. She continued with a 3-year post-doc at the same university, specialising in the same field, studying the mechanisms of action and development of resistance of HIV inhibitors. On joining the Synapse Research Institute in Maastricht in 2013, she left her native Belgium (and HIV) behind to focus on thrombin generation. Her first project concerned the optimisation and clinical validation of a method for measuring thrombin in whole blood. She is now a project leader, involved in the development of new tests relating to platelet function, plasmin generation, fibrin degradation products and von Willebrand factor.

Presentation(s):

• PB0198 - A novel plasminogen activator anti-fibrin-uPA increases the sensitivity of the plasmin generation assay to regulators of fibrinolysis

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0345 - The novel variable heavy chain antibody Syn-VWFA1 inhibits platelet von Willebrand factor interaction in solution

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• OC 47.1 - Evaluation of plasmin generation in severe haemophilia A patients treated with novel therapies

  Monday, June 24, 2024
  14:45 – 15:00 ICT

• PB1411 - Altered whole blood thrombin generation and hyperresponsive platelets associate with thromboembolic events in patients with pancreatic ductal adenocarcinoma

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT